老年抑郁症认知功能损害的早期识别指标研究

注册号:

Registration number:

ChiCTR2100042370 

最近更新日期:

Date of Last Refreshed on:

2021-04-19 14:19:23 

注册时间:

Date of Registration:

2021-01-21 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

老年抑郁症认知功能损害的早期识别指标研究

Public title:

Study on early identification index of cognitive impairment in late-life depression

注册题目简写:

English Acronym:

研究课题的正式科学名称:

老年抑郁症认知功能损害的早期识别指标研究

Scientific title:

Study on early identification index of cognitive impairment in late-life depression

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

刘超猛 

研究负责人:

毛佩贤 

Applicant:

Liu Chaomeng 

Study leader:

Mao Peixian 

申请注册联系人电话:

Applicant telephone:

+86 15352604015

研究负责人电话:

Study leader's
telephone:

+86 13691292180

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

112019000189@ccmu.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

maopeixian@vip.163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市西城区德外大街安康胡同5号

研究负责人通讯地址:

北京市西城区德外大街安康胡同5号

Applicant address:

5 Ankang Lane, Dewai Avenue, Xicheng District, Beijing, China

Study leader's address:

5 Ankang Lane, Dewai Avenue, Xicheng District, Beijing, China

申请注册联系人邮政编码:

Applicant postcode:

100088

研究负责人邮政编码:

Study leader's postcode:

100088

申请人所在单位:

首都医科大学附属北京安定医院老年科

Applicant's institution:

The Geriatrics Department of Beijing Anding Hospital Affiliated to Capital Medical University

研究负责人所在单位:

首都医科大学附属北京安定医院老年科

Affiliation of the Leader:

The Geriatrics Department of Beijing Anding Hospital Affiliated to Capital Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

(2020)科研第(97)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

首都医科大学附属北京安定医院伦理委员会

Name of the ethic committee:

Ethics Committee of Beijing Anding Hospital Affiliated to Capital Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2020-12-17 00:00:00

伦理委员会联系人:

贾京津

Contact Name of the ethic committee:

Jingjin Jia

伦理委员会联系地址:

北京市西城区德外大街安康胡同5号(旧门诊楼东侧2层伦理委员会办公室)

Contact Address of the ethic committee:

5 Ankang Lane, Dewai Avenue, Xicheng District, Beijing, China (Ethics Committee Office, Floor 2, East Side of Old Outpatient Building).

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 10-58340320

伦理委员会联系人邮箱:

Contact email of the ethic committee:

anding_lunli@sina.com

研究实施负责(组长)单位:

首都医科大学附属北京安定医院

Primary sponsor:

Beijing Anding Hospital Affiliated to Capital Medical University

研究实施负责(组长)单位地址:

北京市西城区德外大街安康胡同5号

Primary sponsor's address:

5 Ankang Lane, Dewai Avenue, Xicheng District, Beijing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

首都医科大学附属北京安定医院

具体地址:

西城区德外大街安康胡同5号

Institution
hospital:

Beijing Anding Hospital Affiliated to Capital Medical University

Address:

5 Ankang Lane, Dewai Avenue, Xicheng District

经费或物资来源:

北京市科学技术委员会(Z191100006619105)

Source(s) of funding:

Beijing Municipal Science & Technology Commission Project (Z191100006619105)

研究疾病:

老年抑郁症  

Target disease:

late-life depression

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

本研究采用队列研究的方法,针对老年抑郁症认知功能损害突出,易与老年痴呆相混淆,鉴别诊断困难;且与临床转归密切相关,拟分析与认知环路相关的脑网络及血液相关的生物学指标,发现与老年抑郁症认知功能损害相关的早期生物学识别指标。  

Objectives of Study:

This study adopts the method of cohort study, aiming at the outstanding cognitive impairment of late-life depression, which is easy to be confused with senile dementia and difficult to differentiate and diagnose; And it is closely related to clinical outcome. It is proposed to analyze the brain network related to cognitive circuit and the biological indicators related to blood, and find the early biological identification indicators related to cognitive impairment of late-lfe depression.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

(1)简明精神状态检查表(MMSE)筛查阳性;
(2)排除其他全身系统性疾病及脑部器质性病变所致抑郁状态;
(3)排除既往有头颅疾病、脑部损伤、癫痫发作以及其他神经系统疾病史;
(4)排除严重的心血管系统、呼吸系统、免疫系统等全身性疾病史;
(5)排除有酒精、吗啡类药物滥用史;
(6)排除体内有金属植入物如假牙、动脉夹、起搏器或金属固定物等。

Exclusion criteria:

(1) MMSE was positive;
(2) The depression caused by other systemic diseases and brain organic diseases were excluded;
(3) Previous history of head disease, brain injury, epilepsy and other neurological diseases were excluded;
(4) The history of serious systemic diseases such as cardiovascular system, respiratory system and immune system were excluded;
(5) The history of alcohol and morphine abuse was excluded;
(6) Metal implants such as denture, artery clip, pacemaker or metal fixator were excluded.

研究实施时间:

Study execute time:

From 2019-08-01 00:00:00 To 2023-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-03-01 00:00:00 To 2022-03-01 00:00:00

干预措施:

Interventions:

组别:

伴认知功能损害的首发老年抑郁症患者组

样本量:

150

Group:

First-episode late-life depression patients with cognitive impairment

Sample size:

干预措施:

规范化抗抑郁治疗

干预措施代码:

Intervention:

Standardized antidepressant treatment

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

首都医科大学附属北京安定医院 

单位级别:

三甲 

Institution
hospital:

Beijing Anding Hospital Affiliated to Capital Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

各脑区功能连接水平

指标类型:

主要指标

Outcome:

Brain functional connection

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

脑源性神经营养因子

指标类型:

主要指标

Outcome:

Brain derived neurotrophic factor

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

载脂蛋白E

指标类型:

主要指标

Outcome:

Apo E

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Klotho蛋白

指标类型:

主要指标

Outcome:

Klotho protein

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

β-内分泌酶1

指标类型:

主要指标

Outcome:

BACE 1

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 60 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

非随机对照试验

Randomization Procedure (please state who generates the random number sequence and by what method):

This study is a non randomized study

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

N/A

Blinding:

N/A

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2023年6月30号,首都医科大学附属北京安定医院 请阅读网页注册指南中关于 原始数据共享 的内容。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

June 30, 2023, Beijing Anding Hospital Affiliated to Capital Medical University

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

采用Excel数据表 请阅读网页注册指南中关于 数据收集和管理系统 的内容。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Excel will be used

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2021-01-21 05:27:10